Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Other Non-Current Liabilities (2016 - 2019)

Tenax Therapeutics' Other Non-Current Liabilities history spans 6 years, with the latest figure at $33673.0 for Q4 2017.

  • On a quarterly basis, Other Non-Current Liabilities fell 40.06% to $33673.0 in Q4 2017 year-over-year; TTM through Dec 2017 was $33673.0, a 40.06% decrease, with the full-year FY2017 number at $33673.0, down 40.06% from a year prior.
  • Other Non-Current Liabilities hit $33673.0 in Q4 2017 for Tenax Therapeutics, down from $36078.0 in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for TENX hit a ceiling of $1.1 million in Q1 2014 and a floor of -$33900.0 in Q2 2014.
  • Historically, Other Non-Current Liabilities has averaged $338502.7 across 5 years, with a median of $301856.5 in 2016.
  • Biggest five-year swings in Other Non-Current Liabilities: skyrocketed 1788.63% in 2015 and later plummeted 89.29% in 2016.
  • Tracing TENX's Other Non-Current Liabilities over 5 years: stood at $65592.0 in 2013, then skyrocketed by 992.75% to $716759.0 in 2014, then decreased by 26.85% to $524340.0 in 2015, then plummeted by 89.29% to $56180.0 in 2016, then crashed by 40.06% to $33673.0 in 2017.
  • Business Quant data shows Other Non-Current Liabilities for TENX at $33673.0 in Q4 2017, $36078.0 in Q3 2017, and $72157.0 in Q2 2017.